Vaccine Market Dynamics
Dr. Malone discusses the challenges faced by cancer patients due to prior treatments that compromise their immune systems, making it easier for companies to capitalize on cancer therapies. He highlights the lucrative nature of human vaccines, particularly for pediatric use, and the significant investments made by governments in mRNA technology, which aims to create flexible, rapid-response solutions for emerging infectious diseases.In this clip
From this podcast
Doc Malik
#116 - Robert Malone MD, Inventor of mRNA & DNA vaccines & Freedom Fighter
Related Questions